ADORA2A-AS1 exerts tumor-suppressive roles in HCC via competitively binding HuR, decreasing the binding of HuR to FSCN1 transcript, downregulating FSCN1 transcript stability, repressing FSCN1 expression, and repressing AKT pathway. Here, ADORA2A is linked to hepatocellular carcinoma.